Outcomes of Fludarabine, Melphalan and Total Body Irradiation as a Reduced Intensity Conditioning Regimen in Matched Donor Allogeneic Peripheral Blood Stem Cell Transplantation.
Acute leukemia
Fludarabine
Melphalan
Myelodysplastic syndrome
Non-Hodgkin's lymphoma
Reduced-intensity conditioning regimen
Total body irradiation
Journal
Transplantation and cellular therapy
ISSN: 2666-6367
Titre abrégé: Transplant Cell Ther
Pays: United States
ID NLM: 101774629
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
15
01
2021
revised:
15
03
2021
accepted:
29
04
2021
pubmed:
16
5
2021
medline:
3
8
2021
entrez:
15
5
2021
Statut:
ppublish
Résumé
Fludarabine 30 mg/m
Identifiants
pubmed: 33991722
pii: S2666-6367(21)00891-5
doi: 10.1016/j.jtct.2021.04.029
pii:
doi:
Substances chimiques
Vidarabine
FA2DM6879K
fludarabine
P2K93U8740
Melphalan
Q41OR9510P
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
665.e1-665.e7Informations de copyright
Copyright © 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.